Giovanna Devercelli, PhD
Pinehurst, North Carolina
Head, Rare Diseases, Global Evidence and Outcomes, Takeda Pharmaceuticals
Term Ends August 2024
Giovanna Devercelli serves as Executive Director, Head, Global Evidence and Outcomes Research at Takeda where she leads the Rare Diseases and Plasma Derived Therapies Therapeutic Areas, responsible for creating and executing integrated real-world data/evidence (RWD/E) and clinical outcome assessments (COAs) strategic plans and tactics through evidence generation including patient-centric outcomes (e.g., patient-reported endpoints).
Devercelli possesses over 20 years’ experience spanning clinical research and development, market access, real-world evidence generation (observational study design and execution), clinical outcomes assessments, and health economics. Devercelli has supported numerous regulatory and health technology submissions for products in various therapeutic areas.
Devercelli completed her PhD at the University of Louisiana at Monroe. Born in Lima, Peru, Devercelli loves to play tennis, and has a 16-year-old daughter.
Conflicts of Interest
As of March 31, 2021
- Takeda Pharmaceuticals, Employer
- Amgen, Investments
- Advisory Panel Member
- Advisory Panel on Rare Disease